Search

everythinglearnresearchcommunity

for

Search:↓

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Oenocarpus bataua vegetable oil may help reduce hair loss by affecting a key gene pathway.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Baricitinib can cause excessive hair growth.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

JAK inhibitors may help improve symptoms in adults with APECED.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Deucravacitinib helped a man regrow hair significantly.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Higher STAT3 levels are found in hair loss areas, but not linked to hair loss severity.

Epidermal signaling helps regenerate fingertip tissue.

Activating Tgr5 may help treat hair loss and bone loss.

Hair dye ingredient PPD causes cell death and aging in human hair cells by altering microRNA levels.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Natural products show promise for new hair loss treatments.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Understanding hair follicle development helps create treatments for hair loss and improve hair health.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.